OUR VISION OF THE FUTURE: Arizona is a top-ten life science state.

OUR MISSION: AZBio supports the needs of Arizona’s growing life science ecosystem.

Arizona’s bioscience industry employed 40,399 in 2023 across 3,652 state business establishments, representing a rapid 24.6 percent increase in employment since 2019 and placing the state among the leaders in employment growth. The average wage in the bioscience industry was $102,161—53 percent higher than the state’s private sector average. Academic R&D expenditures in bioscience fields reached a new height of $683.3 million in 2022. NIH funding for Arizona totaled $366.5 million in 2023 following steady annual growth since 2019. Arizona’s bioscience companies attracted strong venture capital investment, with $281.8 million invested in 2023. Arizona stands out in patent activity in bioscience-related technology areas—its 3,387 patent awards from 2019 through 2023 places the state in the second quintile among all states. AZ-BIO2024 - state profile

A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on growing Arizona’s bioscience industry.

AZBio Member Organizations in the fields of business, research and education, health care delivery, economic development, government, and other professions involved in the biosciences are the key drivers of the growth of Arizona's life science sector. As the unified voice of our industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed.

AZBio works nationally and globally with the Advanced Medical Technology Association (AdvaMed), the Biotechnology Innovation Organization (BIO), the Medical Device Manufacturers Association (MDMA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and leading patient advocacy organizations.

Through these relationships, AZBio has access to information, contacts, resources, cost saving programs, and the global bioscience and medtech community.

Guest Post: Philips Healthcare’s Trick or Treat

If you have not been scared enough by Halloween, read this consent decree announcement made by the FDA on November 1 to Philips Healthcare concerning quality control issues with their automatic external defibrillator. Philips had “tricked” industry by consistently providing unsafe defibrillators so the FDA “treated” them to a cease and desist order through a […]

UA Study on Impact of Delays in Diagnosing Valley Fever Funded by CDC

Dr. Fariba Donovan, an infectious diseases research scientist at the University of Arizona College of Medicine – Tucson, receives contract to examine how the failure to diagnose Valley fever impacts patient health, costs and `antimicrobial stewardship’ of this respiratory infection endemic to the U.S. Southwest.

UA Researcher Receives Grant To Study Genetic Risk Factors for Lipedemia

Is It Obesity or Lipedema? UA Researcher Receives Grant To Study Genetic Risk Factors: Yann Klimentidis, PhD, a genetic epidemiologist at the University of Arizona Mel and Enid Zuckerman College of Public Health, has received funding to study the genetic risk factors for developing lipedema, a painful and body disfiguring condition affecting an estimated 11 percent […]

Founding director of ASU’s Biodesign Institute, Charles Arntzen, retires

From his roots as a fair-haired Minnesota farm boy to climbing the ladder of success in big pharma, to blazing a translational academic research path into life-saving therapies, Charles Arntzen has led one extraordinary life in science.